Lazard Asset Management LLC Vanda Pharmaceuticals Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 103,112 shares of VNDA stock, worth $507,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares

103,112

Previous 4,596 2143.52%

Holding current value

$507,311

Previous $25,000 1832.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.61 - $6.34 $454,158 - $624,591	98,516 Added 2143.52%	103,112 $483,000
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $12,770 - $21,229	3,266 Added 245.56%	4,596 $25,000
Q1 2024 May 14, 2024	SELL	$3.47 - $4.61 $4,535 - $6,025	-1,307 Reduced 49.56%	1,330 $5,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $30,578 - $41,435	-9,047 Reduced 77.43%	2,637 $11,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $8,414 - $12,916	1,966 Added 20.23%	11,684 $50,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $41,541 - $48,934	7,041 Added 263.02%	9,718 $64,000
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $6,149 - $7,950	-995 Reduced 27.1%	2,677 $18,000
Q1 2022 May 13, 2022	SELL	$10.84 - $16.55 $303 - $463	-28 Reduced 0.76%	3,672 $41,000
Q4 2021 Feb 09, 2022	BUY	$15.69 - $21.14 $7,546 - $10,168	481 Added 14.94%	3,700 $58,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $5,034 - $6,976	-328 Reduced 9.25%	3,219 $55,000
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $12,923 - $19,529	963 Added 37.27%	3,547 $53,000
Q4 2020 Feb 11, 2021	BUY	$9.77 - $13.81 $17,634 - $24,927	1,805 Added 231.71%	2,584 $33,000
Q3 2020 Nov 13, 2020	SELL	$9.32 - $12.02 $26,301 - $33,920	-2,822 Reduced 78.37%	779 $7,000
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $29,578 - $36,805	-3,062 Reduced 45.96%	3,601 $41,000
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $27,472 - $61,538	3,663 Added 122.1%	6,663 $69,000
Q4 2019 Feb 13, 2020	BUY	$12.38 - $17.47 $21,095 - $29,768	1,704 Added 131.48%	3,000 $49,000
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $15,901 - $20,463	1,296 New	1,296 $17,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.3M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Vanda Pharmaceuticals Inc. Transaction History